Product logins

Find logins to all Clarivate products below.


Endoscope Service | Market Insights | US | 2021

The COVID-19 pandemic will have a significant impact on the US endoscope service market in the short term. Once the market stabilizes, however, the US endoscope service market will expand modestly through 2029, with OEMs continuing to generate the majority of revenues; however, third-party company servicing revenues will grow at a faster rate than those of OEMs, despite the current concerns regarding the possibility of the FDA regulating third-party servicing and the safety concerns surrounding reusable endoscopes.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for endoscope service in the US across a 10-year period.

Related Medtech Insights Reports

Report
Biosurgical Agents – Market Insights – Japan
The Japanese biosurgical agent market is projected to demonstrate a modest growth through 2034, driven by the rising volume of surgical procedures, increasing physician awareness of the clinical…
Report
Biosurgical Agents – Market Insights – Europe
The Europe biosurgical agent market will exhibit modest growth over the forecast period. This expansion will be fueled by a continued preference for biosurgical agents over alternative solutions,…
Report
Biosurgical Agents – Market Insights – US
The biosurgical agent market in the US will experience modest growth through 2034. This growth will be fueled by rising surgical procedure volumes that require biosurgical agent and strong…
Report
Biosurgical Agents – Market Insights – Asia Pacific
The biosurgical agent market in Asia Pacific will experience modest growth through 2034, driven by rising surgical procedure volumes and expanding use of biosurgical agents across a broader range…
Report
Biosurgical Agents – Market Insights – Latin America
The Latin American biosurgical agent market will grow modestly through 2034; although demand for biosurgical agents will rise—supported by favorable regional demographics, expanded indication…